Patrick J. Navin

Patrick J. Navin

Auto-generated profile, based on publicly available information

Patrick J. Navin

Department of Radiology, Mayo Clinic, Rochester, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2015 in American Journal of Roentgenology
Verified
Journal Article
Closed access
BHBarry Donald Hutchinson
Barry Donald Hutchinson
PNPatrick Navin
Patrick Navin
EMEdith M. Marom
Edith M. Marom
MTMylene T. Truong
Mylene T. Truong
JBJohn F. Bruzzi
John F. Bruzzi
OBJECTIVE. The purpose of this study is to evaluate the rate of overdiagnosis of pulmonary embolism (PE) by pulmonary CT angiography (CTA) in a tertiary-care university hospital. MATERIALS AND METHODS. This study is a retrospective review of all pulmonary CTA examinations performed in a tertiary-care university hospital over a 12-month period. Studies originally reported as positive for PE were retrospectively reinterpreted by three subspecialty chest radiologists with more than 10 years’ experience. A pulmonary CTA was considered negative for PE when all three chest radiologists were in agreement that the pulmonary CTA study was negative for PE. The location and potential causes for PE overdiagnosis were recorded. RESULTS. A total of 937 pulmonary CTA studies were performed over the study period. PE was diagnosed in the initial report in 174 of these cases (18.6%). There was discordance between the chest radiologists and the original radiologist in 45 of 174 (25.9%) cases. Discordance occurred more often...

1 March 2024 in Radiology
Verified
Journal Article
Closed access
GCGuilherme Moura Cunha
Guilherme Moura Cunha
BFBoyan Fan
Boyan Fan
PNPatrick J. Navin
Patrick J. Navin
DODamien Olivié
Damien Olivié
SVSudhakar Venkatesh
Sudhakar Venkatesh
ATAn Tang
An Tang
Chronic liver disease is highly prevalent and often leads to fibrosis or cirrhosis and complications such as liver failure and hepatocellular carcinoma. The diagnosis and staging of liver fibrosis is crucial to determine management and mitigate complications. Liver biopsy for histologic assessment has limitations such as sampling bias and high interreader variability that reduce precision, which is particularly challenging in longitudinal monitoring. MR elastography (MRE) is considered the most accurate noninvasive technique for diagnosing and staging liver fibrosis. In MRE, low-frequency vibrations are applied to the abdomen, and the propagation of shear waves through the liver is analyzed to measure liver stiffness, a biomarker for the detection and staging of liver fibrosis. As MRE has become more widely used in clinical care and research, different contexts of use have emerged. This review focuses on the latest developments in the use of MRE for the assessment of liver fibrosis; provides guidance for image acquisition and interpretation; summarizes diagnostic performance, along with thresholds for diagnosis and staging of liver fibrosis; discusses current and emerging clinical applications; and describes the latest technical developments.

1 October 2022 in RadioGraphics
Verified
Journal Article
Closed access
PNPatrick J. Navin
Patrick J. Navin
STScott M. Thompson
Scott M. Thompson
AKAnil Nicholas Kurup
Anil Nicholas Kurup
RLRobert A. Lee
Robert A. Lee
MCMatthew R. Callstrom
Matthew R. Callstrom
JSJohn Joseph Schmitz
John Joseph Schmitz
Radiofrequency ablation of thyroid nodules is a safe and minimally invasive technique that is efficacious in the treatment of benign thyroid nodules, including toxic nodules. Thyroid nodule treatment has significantly evolved over recent years with attempts to individualize treatment on the basis of the cause of the nodule and patient performance status. The risks and c...

1 July 2023 in RadioGraphics
Verified
Journal Article
Closed access
RCRyan Chung
Ryan Chung
JGJoanie Garratt
Joanie Garratt
ERErick M. Remer
Erick M. Remer
PNPatrick Navin
Patrick Navin
MBMichael A. Blake
Michael A. Blake
KEKhaled M. Elsayes
Khaled M. Elsayes
The radiologic diagnosis of adrenal disease can be challenging in settings of atypical presentations, mimics of benign and malignant adrenal masses, and rare adrenal anomalies. Misdiagnosis may lead to suboptimal management and adverse outcomes. Adrenal adenoma is the most common benign adrenal tumor that arises from the cortex, whereas adrenocortical carcinoma (ACC) is a rare malignant tumor of the cortex. Adrenal cyst and myelolipoma are other benign adrenal lesions and are characterized by their fluid and fat content, respectively. Pheochromocytoma is a rare neuroendocrine tumor of the adrenal medulla. Metastases to the adrenal glands are the most common malignant adrenal tumors. While many of these masses have classic imaging appearances, considerable overlap exists between benign and malignant lesions and can pose a diagnostic challenge. Atypical adrenal adenomas include those that are lipid poor; contain macroscopic fat, hemorrhage, and/or iron; are heterogeneous and/or large; and demonstrate growth. Heterogeneous adrenal adenomas may mimic ACC, metastasis, or pheochromocytoma, particularly when they are 4 cm or larger, whereas smaller versions of ACC, metastasis, and pheochromocytoma and those with washout greater than 60% may mimic adenoma. Because of its nonenhanced CT attenuation of less than or equal to 10 HU, a lipid-rich adrenal adenoma may be mimicked by a benign adrenal cyst, or it may be mimicked by a tumor with central cystic and/or necrotic change such as ACC, pheochromocytoma, or metastasis. Rare adrenal tumors such as hemangioma, ganglioneuroma, and oncocytoma also may mimic adrenal adenoma, ACC, metastasis, and pheochromocytoma. The authors describe cases of adrenal neoplasms that they have encountered in clinical practice and presented to adrenal multidisciplinary tumor boards. Key lessons to aid in diagnosis and further guide appropriate management are provided. © RSNA, 2023 Online supplemental material is available for this article. Quiz questions for this article are available through the Online Learning Center.

1 November 2022 in RadioGraphics
Verified
Journal Article
Closed access
PNPatrick J. Navin
Patrick J. Navin
MOMichael C. Olson
Michael C. Olson
MMMishal Mendiratta-Lala
Mishal Mendiratta-Lala
CHChristopher L. Hallemeier
Christopher L. Hallemeier
MTMichael S. Torbenson
Michael S. Torbenson
SVSudhakar Venkatesh
Sudhakar Venkatesh
Stereotactic body radiation therapy (SBRT) is a less invasive treatment option for liver tumors, but knowledge of post-SBRT imaging features of tumors and adjacent parenchyma is needed to properly ... Historically, radiation therapy was not considered in treatment of liver tumors owing to the risk of radiation-induced liver disease. However, development of highly conformed radiation treatments s...

17 February 2019 in Journal of Clinical and Translational Hepatology
Verified
Journal Article
Open access
PDF file
PNPatrick J. Navin
Patrick J. Navin
SVSudhakar Venkatesh
Sudhakar Venkatesh
The incidence of hepatocellular carcinoma (HCC) is increasing, with this trend expected to continue to the year 2030. Hepatocarcinogenesis follows a predictable course, which makes adequate identification and surveillance of at-risk individuals central to a successful outcome. Moreover, imaging is central to this surveillance, and ultimately to diagnosis and management. Many liver study groups throughout Asia, North America and Europe advocate a surveillance program for at-risk individuals to allow early identification of HCC. Ultrasound is the most commonly utilized imaging modality. Many societies offer guidelines on how to diagnose HCC. The Liver Image Reporting and Data System (LIRADS) was introduced to standardize the acquisition, interpretation, reporting and data collection of HCC cases. The LIRADS advocates diagnosis using multiphase computed tomography or magnetic resonance imaging (MRI) imaging. The 2017 version also introduces contrast-enhanced ultrasound as a novel approach to diagnosis. Indeed, imaging techniques have evolved to improve diagnostic accuracy and improve lesion characterization as HCC. Newer techniques, such as T1 mapping, intravoxel incoherent motion analysis and textural analysis, assess specific characteristics that may help grade the tumor and guide management, allowing for a more personalized approach to patient care. This review aims to analyze the utility of imaging in the surveillance and diagnosis of HCC and to assess novel techniques which may increase the accuracy of imaging and determine optimal treatment strategies.